PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22612529-3	2012	The purpose of this study was to investigate the pharmacokinetics of pioglitazone in lean and obese cats, to provide a foundation for assessment of its effects on insulin sensitivity and lipid metabolism.	Pioglitazone	69-81	insulin	Felis catus	163-170	
24592408-0	2014	Effects of pioglitazone on insulin sensitivity and serum lipids in obese cats.	Pioglitazone	11-23	insulin	Felis catus	27-34	
24592408-3	2014	OBJECTIVE: To evaluate the effects of pioglitazone in obese cats, which are predisposed to insulin resistance, to assess its potential for future use in feline diabetes mellitus.	Pioglitazone	38-50	insulin	Felis catus	91-98	
24592408-9	2014	CONCLUSIONS AND CLINICAL IMPORTANCE: Results of this study support a positive effect of pioglitazone on insulin sensitivity and lipid metabolism in obese cats, and suggest that further evaluation of the drug in cats with diabetes mellitus or other metabolic disorders might be warranted.	Pioglitazone	88-100	insulin	Felis catus	104-111